Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients (2021) Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, et al. Journal article The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival (2021) Vitali F, Wein A, Rath T, Eckstein M, Neufert C, Siebler J, Atreya R, et al. Journal article Novel criteria for intratumoral budding with prognostic relevance for colon cancer and its histological subtypes (2021) Pour Farid P, Eckstein M, Merkel S, Grützmann R, Hartmann A, Bruns V, Benz M, et al. Journal article DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base Detailed Clinicopathologic Characterization of a Distinctive Entity (2021) Rooper LM, Agaimy A, Dickson BC, Dueber JC, Eberhart CG, Gagan J, Hartmann A, et al. Journal article Risk of penile tumor development in Caucasian individuals is independent of the coding variant rs7208422 in the TMC8 (EVER2) gene (2021) Stöhr R, Wendler OD, Giedl J, Richter G, Campean V, Burger M, Bertz S, et al. Journal article Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer (2021) Eckstein M, Kimmel C, Bruendl J, Weber F, Denzinger S, Gierth M, Burger M, et al. Journal article SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report (2021) Gerber TS, Agaimy A, Hartmann A, Habekost M, Roth W, Stenzinger A, Schirmacher P, Straub BK Journal article Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors (2021) Ali N, Bolenz C, Todenhöfer T, Stenzel A, Deetmar P, Kriegmair M, Knoll T, et al. Journal article An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer (2021) Lindskrog SV, Prip F, Lamy P, Taber A, Groeneveld CS, Birkenkamp-Demtröder K, Jensen JB, et al. Journal article MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma (2021) Kang EY, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, et al. Journal article